| 回购方案首次披露日 | 2024/2/20，由公司控股股东、实际控制人、董事 | | --- | --- | | | 长、总经理黄源浩先生提议 | | 回购方案实施期限 | 本次回购用于维护公司价值及股东权益的期限为 自公司第二届董事会第三次会议审议通过回购方 案之日起不超过 个月，用于员工持股计划或股 | | | 3 | | | 权激励的期限为自公司第二届董事会第三次会议 | | | 审议通过回购方案之日起不超过 12 个月。 | | 预计回购金额 | 2,500 万元~5,000 万元 | | 回购用途 | □减少注册资本 | | | √用于员工持股计划或股权激励 | | | □用于转换公司可转债 | | | √为维护公司价值及股东权益 | | 累计已回购股数 | 1,200,971 股 | | 累计已回购股数占总股本比例 | 0.30% | | 累计已回购金额 | 3,382.69 万元 | | 实际回购价格区间 | 23.23 元/股~33.42 元/股 | 证券代码：688322 证券简称：奥比中光 公告编号：2024-079 奥比中光科技集团股份有限公司 关于以集中竞价交易方式回购公司股份的进 ...

奥比中光科技集团股份有限公司 2024 年第二次临时股东会会议资料 证券代码：688322 证券简称：奥比中光 奥比中光科技集团股份有限公司 2024 年第二次临时股东会会议资料 2024 年 11 月 奥比中光科技集团股份有限公司 2024 年第二次临时股东会会议资料 奥比中光科技集团股份有限公司 2024 年第二次临时股东会会议资料目录 | 奥比中光科技集团股份有限公司 | 2024 年第二次临时股东会会议须知 1 | | --- | --- | | 奥比中光科技集团股份有限公司 | 2024 年第二次临时股东会会议议程 3 | | 议案一： 关于公司《2024 | 年限制性股票激励计划（草案）》及其摘要的议案 ... 5 | | 议案二： 关于公司《2024 | 年限制性股票激励计划考核管理办法》的议案 6 | | 议案三： 关于提请股东会授权董事会办理公司 | 2024 年限制性股票激励计划相关事 | | 项的议案 7 | | | 议案四： 关于向控股子公司提供财务资助展期的议案 9 | | 奥比中光科技集团股份有限公司 2024 年第二次临时股东会会议资料 奥比中光科技集团股份有限公司 2024 年 ...

Investment Rating - The investment rating for the company is maintained at "Buy - A" with a 6-month target price of 37.8 CNY, compared to the current stock price of 33.55 CNY [4]. Core Insights - The company reported a revenue of 351 million CNY for the first three quarters of 2024, representing a year-on-year growth of 35.27%. The net profit attributable to shareholders was a loss of 60 million CNY, significantly narrowing the loss compared to the same period last year [1][2]. - The company has successfully controlled costs, with R&D expenses and management expenses decreasing by 35% and 17% year-on-year, respectively. This cost control, combined with high revenue growth, is expected to lead to clearer paths to breakeven [2]. - A stock incentive plan was announced, aimed at key R&D personnel and foreign core staff, indicating the company's confidence in future growth [3]. - The company is focusing on robotics applications, leveraging its 3D vision technology, which is expected to drive significant growth as the technology becomes essential in various sectors [4][8]. Revenue and Profitability - The company achieved a revenue of 138 million CNY in Q3 2024, marking a 46.27% year-on-year increase, indicating successful application of its 3D vision technology in various fields [2]. - The projected revenues for 2024, 2025, and 2026 are 504 million CNY, 724 million CNY, and 1,040 million CNY, respectively, with expected net profits of -93 million CNY, 18 million CNY, and 133 million CNY [8][10]. Market Position and Strategy - The company is positioned as a leading global consumer-grade 3D vision manufacturer, with a comprehensive layout that enhances its competitive advantage. The shift of 3D vision sensors from optional to essential is expected to propel the company into a rapid growth phase [8]. - The introduction of the Gemini 335 and 336 series products is aimed at various robotics and AI vision applications, enhancing the company's product offerings [4][7]. Financial Metrics - The company reported a net profit margin of -82.8% in 2022, improving to -76.6% in 2023, with expectations of reaching a positive margin of 2.5% by 2025 [10][12]. - The projected earnings per share (EPS) are expected to improve from -0.72 CNY in 2022 to 0.33 CNY by 2026 [12].

Investment Rating - The report maintains a "Buy" rating for the company [2][4]. Core Views - The company's Q3 2024 financial results show a continued narrowing of losses, with revenue reaching 351 million yuan, a year-on-year growth of 35.27%. The net profit attributable to shareholders was -60 million yuan, improving by 68.58% year-on-year [1]. - The company has implemented an equity incentive plan, reflecting confidence in future development, with a total of 539,300 restricted shares to be granted [1]. - The report anticipates significant revenue growth in the coming years, with projected revenues of 575 million yuan, 863 million yuan, and 1.164 billion yuan for 2024E, 2025E, and 2026E respectively, representing year-on-year growth rates of 59.8%, 50.1%, and 34.8% [2][4]. Financial Summary - Q3 2024 operating revenue was 138 million yuan, with a year-on-year growth of 46.27%. The net profit attributable to shareholders for the quarter was 700,000 yuan, up 86.59% year-on-year [1]. - The company’s expense ratio decreased significantly to 71.26% in Q3 2024, down 69.61 percentage points year-on-year, indicating improved profitability [1]. - The projected net profit for 2024E is -68 million yuan, with subsequent years showing a turnaround to positive net profits of 45 million yuan in 2025E and 129 million yuan in 2026E [2][4].

Company News - The company announced a restricted stock incentive plan for 2024, proposing to grant 539,300 restricted shares, accounting for approximately 0.13% of the total share capital at the time of the announcement [1]

Revenue and Profit - Revenue for the third quarter reached 137.55 million yuan, a year-on-year increase of 46.27%[2] - Year-to-date revenue totaled 350.86 million yuan, up 35.27% compared to the same period last year[2] - Net profit attributable to shareholders for the third quarter was -6.93 million yuan, with no applicable year-on-year comparison[2] - Year-to-date net profit attributable to shareholders was -60.31 million yuan, with no applicable year-on-year comparison[2] - Total revenue for the first three quarters of 2024 reached 350,864,553.18 RMB, a significant increase from 259,373,251.38 RMB in the same period of 2023[17] - Net profit for the first three quarters of 2024 was -1,648,224,350.14 RMB, an improvement from -1,587,917,829.86 RMB in the same period of 2023[15] - Net loss for the third quarter of 2024 was RMB 59.38 million, compared to a net loss of RMB 205.03 million in the same period last year[18] - Revenue from sales of goods and services for the first three quarters of 2024 was RMB 379.21 million, a 42.6% increase from RMB 265.85 million in the same period last year[21] - Cash received from customers for goods and services in the first three quarters of 2024 was RMB 379.21 million, a 42.6% increase from RMB 265.85 million in the same period last year[21] R&D Investment - R&D investment for the third quarter was 47.26 million yuan, a decrease of 31.72% year-on-year[2] - Year-to-date R&D investment was 153.31 million yuan, down 35.48% compared to the same period last year[2] - R&D investment as a percentage of revenue for the third quarter was 34.36%, a decrease of 39.25 percentage points year-on-year[4] - Year-to-date R&D investment as a percentage of revenue was 43.70%, a decrease of 47.92 percentage points year-on-year[4] - R&D expenses for the first three quarters of 2024 were 153,313,676.93 RMB, a decrease from 237,632,719.00 RMB in the same period of 2023[17] Assets and Liabilities - Total assets at the end of the reporting period were 3.24 billion yuan, a decrease of 4.21% compared to the end of the previous year[4] - Equity attributable to shareholders at the end of the reporting period was 2.94 billion yuan, a decrease of 2.68% compared to the end of the previous year[4] - Monetary funds as of September 30, 2024: 546,079,884.79[13] - Transactional financial assets as of September 30, 2024: 483,007,685.53[13] - Accounts receivable as of September 30, 2024: 95,436,590.79[13] - Inventory as of September 30, 2024: 199,146,028.98[13] - Fixed assets as of Q3 2024 were 269,292,355.78 RMB, down from 286,300,664.39 RMB in the previous period[14] - Construction in progress increased significantly to 86,868,117.89 RMB in Q3 2024, up from 3,667,448.68 RMB in the previous period[14] - Total assets as of Q3 2024 were 3,241,620,466.53 RMB, slightly lower than 3,384,218,429.36 RMB in the previous period[14] - Short-term borrowings decreased to 92,063,044.44 RMB in Q3 2024, down from 147,511,378.14 RMB in the previous period[14] - Total liabilities as of Q3 2024 were 298,253,656.29 RMB, a decrease from 373,691,931.20 RMB in the previous period[15] - Shareholders' equity as of Q3 2024 was 2,943,366,810.24 RMB, slightly lower than 3,010,526,498.16 RMB in the previous period[15] Shareholders and Equity - Total number of ordinary shareholders at the end of the reporting period: 11,989[9] - Huang Yuanhao holds 108,903,960 shares, accounting for 27.23% of the total shares[9] - Shanghai Yunxin Venture Capital Co., Ltd. holds 48,822,120 shares, accounting for 12.21% of the total shares[9] - Zhou Guangda holds 26,968,320 shares, accounting for 6.74% of the total shares[9] - Zhuhai Obzhongxin Equity Investment Partnership holds 22,407,480 shares, accounting for 5.60% of the total shares[9] - Qianhai Renzhi Interconnection (Shenzhen) Equity Investment Enterprise holds 10,225,863 shares, accounting for 2.56% of the total shares[9] Cash Flow - Operating cash flow for the first three quarters of 2024 was negative RMB 60.58 million, an improvement from negative RMB 185.00 million in the same period last year[21] - Cash and cash equivalents at the end of the third quarter of 2024 were RMB 212.55 million, a significant decrease from RMB 1.04 billion at the end of the same period last year[22] - Investment cash flow for the first three quarters of 2024 was negative RMB 511.52 million, compared to positive RMB 129.95 million in the same period last year[22] - Cash paid for goods and services in the first three quarters of 2024 was RMB 241.97 million, a 66.6% increase from RMB 145.23 million in the same period last year[21] - Cash received from investments in the first three quarters of 2024 was RMB 1.19 billion, a 34.5% decrease from RMB 1.82 billion in the same period last year[21] Earnings and Losses - Basic and diluted earnings per share for the third quarter of 2024 were both negative RMB 0.15, compared to negative RMB 0.48 in the same period last year[19] - Total comprehensive loss for the third quarter of 2024 was RMB 59.29 million, compared to RMB 204.51 million in the same period last year[19] Operating Costs - Operating costs for the first three quarters of 2024 were 448,143,227.25 RMB, compared to 511,808,369.76 RMB in the same period of 2023[17]

证券代码：688322 证券简称：奥比中光 公告编号：2024-071 奥比中光科技集团股份有限公司 第二届董事会第九次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 奥比中光科技集团股份有限公司（以下简称"公司"）第二届董事会第九次会 议通知于 2024 年 10 月 21 日以电话、电子邮件等方式向全体董事、监事及高级管理 人员发出，会议于 2024 年 10 月 24 日在公司会议室以现场结合通讯表决方式召开。 本次会议由公司董事长黄源浩先生主持，会议应出席董事 10 名，实际出席董事 10 名（其中 5 名董事以通讯表决方式出席会议），公司全体监事和高级管理人员列席 本次会议。本次会议的召集、召开及表决程序符合《中华人民共和国公司法》（以 下简称"《公司法》"）等法律、行政法规、规范性文件和《奥比中光科技集团股 份有限公司章程》（以下简称"《公司章程》"）的规定，合法有效。 《奥比中光科技集团股份有限公司 2024 年限制性股票激励计划考核管理办法》 （以下简称"《2024 年 ...

北京市金杜（深圳）律师事务所 关于奥比中光科技集团股份有限公司 2024 年限制性股票激励计划（草案） 之 法律意见书 致：奥比中光科技集团股份有限公司 北京市金杜（深圳）律师事务所（以下简称金杜或者本所）接受奥比中光科技 集团股份有限公司（以下简称公司或奥比中光）的委托，根据《中华人民共和国公 司法》（以下简称《公司法》）、《中华人民共和国证券法》（以下简称《证券法》）、 中国证券监督管理委员会（以下简称中国证监会）《上市公司股权激励管理办法》 （以下简称《管理办法》）、上海证券交易所（以下简称上交所）《上海证券交易所 科创板股票上市规则》（以下简称《上市规则》）、《科创板上市公司自律监管指南第 4 号——股权激励信息披露》（以下简称《自律监管指南第 4 号》）等法律、行政法 规、部门规章及其他规范性文件（以下简称法律法规）和《奥比中光科技集团股份 有限公司章程》（以下简称《公司章程》）的有关规定，就公司拟实施 2024 年限制 性股票激励计划（以下简称本激励计划）所涉及的相关事项，出具本法律意见书。 本所及经办律师依据《证券法》《律师事务所从事证券法律业务管理办法》和 《律师事务所证券法律业务执业规则（试 ...

证券代码：688322 证券简称：奥比中光 公告编号：2024-074 一、征集人声明 奥比中光科技集团股份有限公司 本人徐雪妙作为征集人，按照《管理办法》的有关规定及其他独立董事的委 托，就公司 2024 年第二次临时股东会审议的本次激励计划相关提案公开征集股 东委托投票权而制作并签署本公告。 本人不存在中国证监会《公开征集上市公司股东权利管理暂行规定》第三条 规定的不得作为征集人公开征集投票权的情形，并承诺在征集日至行权日期间持 续符合作为征集人的条件。征集人保证本公告不存在虚假记载、误导性陈述或重 大遗漏，并对其真实性、准确性、完整性承担法律责任，保证不会利用本次征集 投票权从事内幕交易、操纵市场等证券欺诈行为。 本次征集委托投票权行动以无偿方式公开进行，在信息披露媒体上海证券交 易所网站（www.sse.com.cn）上公告。本次征集行动完全基于征集人作为上市公 征集委托投票权的起止时间：2024年11月6日（9:00-12:00，13:30-18:00） 征集人对所有表决事项的表决意见：同意 征集人未持有公司股票 关于独立董事公开征集委托投票权的公告 本公司董事会及全体董事保证本公告内容不存在任何虚 ...

奥比中光科技集团股份有限公司 2024 年限制性股票激励计划激励对象名单 3、以上合计数据与各明细数据相加之和在尾数上如有差异，系由于四舍五入所致。 二、其他激励对象名单 | 激励对象类别 | 激励对象人数 | 占本次激励计划授予总人数的比例 | | --- | --- | --- | | 研发骨干 | 2 | 40.00% | | 职能骨干 | 3 | 60.00% | | 小计 | 5 | 100.00% | 奥比中光科技集团股份有限公司 一、限制性股票激励计划分配情况表 | 姓名 | 职务 | 国籍 | 获授数量 （万股） | 占授予总 量的比例 | 占股本总 额的比例 | | --- | --- | --- | --- | --- | --- | | 一、董事、高级管理人员 | | | | | | | / | / | / | / | / | / | | 二、其他激励对象 | | | | | | | 外籍人员（3 人） | | | 41.93 | 77.75% | 0.10% | | 公司董事会认为应当激励的其他人员（2 | | 人） | 12.00 | 22.25% | 0.03% | | 合计 | ...